Post Medical Surveillance necessary to reshuffle.

In the discussion meeting for the drug safety system, its present status and future improvement jointly sponsored by Hyun Aeja Clinics and Keonyak, Mr. Kim Seong-eun of LG Life Science said that the current post market surveillance (PMS) system raised many problems and should be reshuffled at quite a lot.

Mr. Kim said that the system exposed too uniformed standards for the surveillance perio...